Related Experiment Video
Updated: Feb 6, 2026

12:40
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
Published on: December 7, 2014
15.3K
The BTK Inhibitor ARQ 531 Targets Ibrutinib-Resistant CLL and Richter Transformation
Sean D Reiff1,2, Rose Mantel1, Lisa L Smith1
1Department of Internal Medicine, Division of Hematology, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
Cancer Discovery
|August 11, 2018
Summary
A new drug, ARQ 531, shows promise in treating chronic lymphocytic leukemia (CLL) by reversibly inhibiting Bruton tyrosine kinase (BTK) and other related kinases, outperforming ibrutinib in preclinical models.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Bruton tyrosine kinase (BTK) inhibitors like ibrutinib have improved outcomes in hematologic malignancies.
- Acquired resistance to BTK inhibitors, particularly mutations in BTK and PLCγ2, remains a clinical challenge.
Purpose of the Study:
- To investigate ARQ 531, a reversible BTK inhibitor with additional activity against Src family kinases and ERK-related kinases.
- To evaluate the efficacy of ARQ 531 in preclinical models of chronic lymphocytic leukemia (CLL) and Richter transformation, including models of ibrutinib resistance.
Main Methods:
- In vitro studies using patient CLL cells to assess ARQ 531's effects on B-cell receptor (BCR) signaling, viability, migration, and gene transcription.
- In vivo studies using murine engraftment models (Eμ-TCL1 and Eμ-MYC/TCL1) to evaluate survival and therapeutic efficacy compared to ibrutinib.
- Assessment of ARQ 531's activity against resistant BTK (C481S) and PLCγ2 mutants.
Main Results:
- ARQ 531 effectively decreased BTK-mediated functions in CLL cells in vitro.
- ARQ 531 significantly increased survival in murine models of CLL and Richter transformation compared to ibrutinib.
- ARQ 531 inhibited CLL cell survival and suppressed BCR-mediated activation of resistant BTK and PLCγ2 mutants.
Conclusions:
- ARQ 531 is a potent, reversible multi-kinase inhibitor with promising preclinical efficacy in CLL.
- ARQ 531 demonstrates superior efficacy to ibrutinib in models of Richter transformation and overcomes common resistance mechanisms to ibrutinib.
Related Concept Videos
Bacterial Transformation
60.1K
In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
60.1K
Eukaryotic Transcription Inhibitors
11.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
Resistivity
4.6K
When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.6K
Resistance
6.0K
When a current moves through any conductor, the conductor causes some level of difficulty for the current to flow. The measure of that difficulty is known as the resistance of the material and is represented by R. Every material has its own resistance. In the case of conductors, heat is emitted whenever a current passes through them. Resistance depends on the resistivity of the material. Resistivity is a characteristic of the material used to fabricate electrical components, whereas the...
6.0K
Transformers
1.9K
A device that transforms voltages from one value to another using induction is called a transformer. A transformer consists of two separate coils, or windings, wrapped around the same soft iron core. However, they are electrically insulated from each other.
The iron core has a substantial relative permeability. Therefore, the magnetic field lines generated due to the current in one winding are almost entirely confined within the core, such that the same magnetic flux permeates each turn of both...
The iron core has a substantial relative permeability. Therefore, the magnetic field lines generated due to the current in one winding are almost entirely confined within the core, such that the same magnetic flux permeates each turn of both...
1.9K
Transformation
1.1K
Microbial communities are dynamic environments where cell lysis releases free DNA into the surroundings. Other cells can take up this extracellular DNA through a process known as transformation.When a cell incorporates this foreign DNA into its genome, resulting in genetic modification, the process is known as transformation. Cells capable of this process are termed competent. Competence can be natural, as observed in certain bacteria and archaea, or artificially induced in the...
1.1K

